Am J Gastroenterol
- TAPPER EB, Kardashian A, Debes J, Gripshover J, et al
ACG Clinical Guideline: Preventive Care for Patients With Cirrhosis.
Am J Gastroenterol. 2026 Oct 5. doi: 10.14309/ajg.0000000000004186.
Biochem Biophys Res Commun
- JAIN R, Puri V, Mungamuri SK, Garg P, et al
Integrative predictive modelling and multi-omics validation reveals potential
indicators of clinical heterogeneity in HCC.
Biochem Biophys Res Commun. 2026;837:154590.
- QIANG Z, Qin K, Zhou Y, Huang T, et al
Dicoumarol suppresses intrahepatic cholangiocarcinoma growth via modulation of
the PI3K/Akt signaling pathway.
Biochem Biophys Res Commun. 2026;839:154686.
- LIU M, Liu Z, Leng Y, Zhang Q, et al
ZSP1601 is a non-selective phosphodiesterase inhibitor and a clinical drug
candidate for the oral treatment of metabolic dysfunction-associated
steatohepatitis.
Biochem Biophys Res Commun. 2026;839:154684.
- BI J, Sun K, Wu H, Chen X, et al
Corrigendum to "PPARgamma alleviated hepatocyte steatosis through reducing SOCS3 by
inhibiting JAK2/STAT3 pathway" [Biochem. Biophys. Res. Commun. 498, (2018),
1037-1044].
Biochem Biophys Res Commun. 2026;837:154653.
- LUO H, Yang Y, Wen J, Hou Y, et al
Mitophagy-related gene signatures predict prognosis and therapeutic response in
hepatocellular carcinoma.
Biochem Biophys Res Commun. 2026;838:154646.
BMC Gastroenterol
- AWAIS AM, Das V, Wassam M, Mahsud NJ, et al
Temporal trends and demographic disparities in mortality with co-mention of
chronic liver disease and pneumonia in the United States, 1999-2024.
BMC Gastroenterol. 2026;26:623.
- WEISNER L, Wehmeyer M, Sebode M, Schulze Zur Wiesch J, et al
Superior diagnostic yield of mini-laparoscopy over transjugular liver biopsy in
acute-on-chronic liver failure: a case-control study.
BMC Gastroenterol. 2026;26:616.
- BAGHERI H, Seighali N, Gholami-Chahkand MS, Bakhtiyari M, et al
Diagnostic performance of FIB-6 for identifying FibroScan-defined advanced
fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): a
cross-sectional diagnostic accuracy study.
BMC Gastroenterol. 2026;26:608.
- XIONG XS, Cheng FZ, Qi WN, Cheng J, et al
Association between the TyG/HDL-C ratio and non-alcoholic fatty liver disease: a
single-centre retrospective study.
BMC Gastroenterol. 2026;26:626.
Cancer Res
- GUO Z, Li Z, Lei T, Ren Y, et al
ANXA1 Promotes Endoplasmic Reticulum-Mitochondria Calcium Coupling to Sustain
Lenvatinib Resistance in Hepatocellular Carcinoma.
Cancer Res. 2026 Oct 8. doi: 10.1158/0008-5472.CAN-26-2074.
Eur Radiol
- PARK J, Lim GS, Ko Y, Shin H, et al
Preoperative radioembolization versus chemoembolization and upfront resection for
resectable hepatocellular carcinoma beyond the Milan criteria.
Eur Radiol. 2026 Oct 7. doi: 10.1007/s00330-026-12920.
Gut
- LIEBE R, Lammert F, Schmidt HH, Krawczyk M, et al
Use of genetic analysis in adult cholestatic liver disease: lessons from
progressive paediatric syndromes and cohort studies.
Gut. 2026 Jun 17:gutjnl-2025-337027. doi: 10.1136/gutjnl-2025-337027.
- CHEN Y, Jin GW, He LH, Dong Y, et al
MTFP1 drives pancreatic cancer liver metastatic colonisation by regulating
mitochondrial metabolism reprogramming.
Gut. 2026 Feb 9:gutjnl-2025-336323. doi: 10.1136/gutjnl-2025-336323.
- BEN KHALED N, Enssle S, Ricke J, Mayerle J, et al
Rapid muscle loss beyond the transplant waiting list: outcomes in
immunotherapy-treated hepatocellular carcinoma.
Gut. 2026 Oct 7:gutjnl-2026-340713. doi: 10.1136/gutjnl-2026-340713.
Hepatology
- WANG K, Du M
Deciphering the post-transcriptional code in tumor progression: CPEB3 links
genetic variation to alternative polyadenylation in hepatocellular carcinoma.
Hepatology. 2026 Oct 7. doi: 10.1097/HEP.0000000000001882.
J Gastroenterol Hepatol
- HUANG CF, Liang PC, Huang CK, Stec M, et al
The Clinical Utility of Adding Laminin Gamma 2 Monomer to the PAGE-B Score for
Hepatocellular Carcinoma Surveillance in Chronic Hepatitis B.
J Gastroenterol Hepatol. 2026 Oct 8. doi: 10.1111/jgh.70792.
- HONMA Y, Shimose S, Ito T, Saeki I, et al
Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular
Carcinoma Treated With Durvalumab Plus Tremelimumab.
J Gastroenterol Hepatol. 2026 Oct 5. doi: 10.1111/jgh.70793.
J Hepatol
- CHAN SL, Kudo M, Sangro B, Kelley RK, et al
First-line durvalumab and tremelimumab in poor-prognosis unresectable
hepatocellular carcinoma: Phase IIIb single-arm SIERRA study.
J Hepatol. 2026 Oct 6:S0168-8278(26)02919-3. doi: 10.1016/j.jhep.2026.
J Pediatr Surg
- PEDERIVA F, Gentilino V, Bonanno C, Bertelli E, et al
CONGENITAL HEPATOPULMONARY FUSION IN RIGHT CONGENITAL DIAPHRAGMATIC HERNIA:
SURGICAL STRATEGY AND OUTCOMES IN A MULTICENTER COHORT.
J Pediatr Surg. 2026 Oct 7:163521. doi: 10.1016/j.jpedsurg.2026.163521.
Oncogene
- TANG Q, Slarve I, Chen J, Zeng N, et al
PTEN-AKT2 regulates mixed lineage liver cancer development and sensitizes cancer
cells to TGFbeta treatment.
Oncogene. 2026;45:4362-4376.
PLoS One
- OOMMEN TT, Philips CA, Theruvath AH, Ravindran R, et al
Admission interleukin-6 as a time-limited, etiology-dependent prognostic signal
in hospitalized cirrhosis - A frequentist and Bayesian cohort study.
PLoS One. 2026;21:e0360005.
- ZHANG X, Wang X, Li N, Han Q, et al
Association of 5-hydroxytryptamine 3 receptor antagonists with prognosis in
patients with advanced hepatocellular carcinoma: A propensity score-matched
study.
PLoS One. 2026;21:e0359798.
- LIN L, Weng N, Lai H, Wu G, et al
Integrated multi-omic analysis characterizes an
IFNgamma-responsive-to-myeloid-suppressive immune continuum in immune-active
hepatocellular carcinoma.
PLoS One. 2026;21:e0359327.
- SCHUTTE SL, Heidrich B, Wedemeyer H, Maasoumy B, et al
Novel peritoneal catheters with silver particles lower rates of peritonitis in
patients with cirrhosis and refractory ascites.
PLoS One. 2026;21:e0359408.
- ZUO Z, Yang C, Hu L, Ye X, et al
Superior diagnostic efficacy and cost advantage of FibroTouch over CHI3L1 for
liver fibrosis in Chinese patients with chronic liver disease.
PLoS One. 2026;21:e0357883.
Proc Natl Acad Sci U S A
- WU H, Shen X, Zhao T, Zhang H, et al
Mechanotherapy enhances nanodrug uptake by overcoming the actin cytoskeleton
damping effect.
Proc Natl Acad Sci U S A. 2026;123:e2600686123.
Radiology
- DING W, Ji R, Pang C, Li J, et al
Perfusion beyond Margin in Hepatocellular Carcinoma: A Contrast-enhanced US
Feature Related to Tumor Invasiveness and Prognosis.
Radiology. 2026;321:e260918.
- SERAI SD, Pepin K, Chen J, Venkatesh SK, et al
Standardizing Liver MR Elastography: Guidelines for Reliable Stiffness
Measurement in Chronic Liver Disease.
Radiology. 2026;321:e260974.
- SHAFAAT O, Reis SP
Implications for Hepatocellular Carcinoma Ablation beyond the Tumor Margin: An
Early Career Perspective.
Radiology. 2026;321:e262757.
Transplant Proc
- LIU Y, Liu Y, Dai C, Gu M, et al
A Kidney Transplant Patient Suffering From Multiple Colonic Ulcers and Hepatic
Abscess: A Case Report and Literature Review.
Transplant Proc. 2026 Oct 3:S0041-1345(26)00429.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016